-transparent.png){kind=logo}
1 The effects of mianserin (60 mg) have been studied on nocturnal and pentagastrin-stimulated gastric secretion. 2 Mianserin reduced pentagastrin-stimulated gastric acid secretion by 38%, pepsin by 40% and secretory volume by 45% during a 1 h test. 3 Twelve-hour overnight secretion of acid was reduced by 37%, while secretion of pepsin was reduced by 43% and secretory volume by 51%. 4 No adverse effects were noted. 5 These findings, which achieve statistical significance, suggest the need for further study to evaluate the possible role of mianserin in the therapy of duodenal ulcer disease.
Related Publications
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
February 1981,
Lancet (London, England),
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
November 1979,
Deutsche medizinische Wochenschrift (1946),
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
June 1980,
American journal of surgery,
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
April 1972,
The Journal of physiology,
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
March 1972,
Gastroenterology,
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
May 1982,
Lancet (London, England),
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
January 2006,
Digestive diseases and sciences,
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
January 1972,
Lancet (London, England),
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
August 1972,
The American journal of physiology,
J A Wilson, and
J R Read, and
E J Boyd, and
K G Wormsley
January 1982,
Digestion,
